2022 Webinar Archive

Oftentimes, the duty to “do no harm” is implicitly implied to assume another duty: a duty to promote health and well-being. But, what is “health” and what is “well-being”? Our answer has large implications on the goals in medicine.

Discussions regarding U.S. immigration enforcement efforts occur primarily within the social/political dimension. These debates focus on the legality of U.S. immigration policies; however, there is another important dimension here. Namely, the health consequences of U.S. immigration enforcement efforts.

Recent shortages of pharmaceuticals have caused physicians, pharmacists, and patients to make tough decisions. Dr. Summer Peregrin leads us in a discussion of the effects of drug shortages on patient care from the perspective of the hospital pharmacist.

Michael Yudell, PhD, MPH examines the history of the use of race concepts in health and genetics research, considering the evolution of thinking on this topic, ethical issues associated with the use of race and other population identifiers, and practical and policy challenges related to the use and misuse of population identifiers in this webinar.

Recently a nurse was criminally prosecuted after a medical mistake that caused the death of a patient. In this panel discussion moderated by Leah Veschio, RN, MSN, CLNC, we will hear some of the demands asked of nurses and administrators in today’s medical environment. Join the conversation.

Indigenous people still constitute <1% of participants in precision and genomic medicine research despite endeavors to increase inclusivity. Past ethical issues related to Indigenous genomics have not been adequately reconciled and are now being repeated in the new era of Big Data.

As cyberhackers become more sophisticated, we’ve seen instances where they have infiltrated the electronic record systems of hospitals. What does it mean to a hospital system when such a cyberattack occurs? In the case linked here, no ransomware was paid, but the cost to the hospital system was $50 million, and created delays in care for patients.

Dr. Mayer is the Psychiatric Medical Director, Division of Youth Services, Colorado. She is Board Certified in Adult, Child and Adolescent Psychiatry and is a Forensic Psychiatry Fellow at University of Colorado. In this webinar she discusses some of the ethical challenges in providing mental health services to incarcerated youth.

It can be challenging managing a patient in the hospital who is under guard by jail or prison officers. This webinar will address the common challenging questions that arise, such as: What are their rights with regard to medical decision-making? What do you do with a patient who lacks decision-making capacity?

On June 7, 2021, the US Food and Drug Administration (FDA) approved aducanumab (Aduhelm; Biogen Inc), the first new drug for the treatment of Alzheimer disease in 2 decades. The approval of the drug, however, by FDA has not been without controversy and therefore, ethical challenges, as there are questions about its value.